Skip Navigation

JNCI Journal of the National Cancer Institute 2008 100(4):227; doi:10.1093/jnci/djn029
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Recurrence Risk Perceptions of Women with DCIS

Women who are diagnosed with ductal carcinoma in situ (DCIS) have a good prognosis, but many overestimate their risk of DCIS recurrence and invasive breast cancer. Little is known about the psychosocial outcomes of women who are recently diagnosed with DCIS and whether these outcomes are associated with their perceptions of DCIS recurrence and invasive breast cancer. Partridge et al. (p. 243) surveyed almost 500 women in eastern Massachusetts who had been diagnosed with DCIS within the past 6 months. At enrollment, 54% of women surveyed . . . [Full Text of this Article]

Competing Causes of Death in Breast Cancer Patients by Age

Head and Neck Squamous Cell Carcinoma Outcomes and HPV

Adverse Event Reporting and Targeted Therapies

DNA Repair Gene Variants and Meningioma Risk in Europeans

Muir-Torre Syndrome Frequency Among Lynch Syndrome Families


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

The Frequency of Muir-Torre Syndrome Among Lynch Syndrome Families
Christopher D. South, Heather Hampel, Ilene Comeras, Judith A. Westman, Wendy L. Frankel, and Albert de la Chapelle
J Natl Cancer Inst 2008 100: 277-281. [Abstract] [Full Text] [PDF]

Is There Room for Improvement in Adverse Event Reporting in the Era of Targeted Therapies?
Maureen Edgerly and Tito Fojo
J Natl Cancer Inst 2008 100: 240-242. [Abstract] [Full Text] [PDF]

Comprehensive Analysis of DNA Repair Gene Variants and Risk of Meningioma
Lara Bethke, Anne Murray, Emily Webb, Minouk Schoemaker, Kenneth Muir, Patricia McKinney, Sarah Hepworth, Polyxeni Dimitropoulou, Artitaya Lophatananon, Maria Feychting, Stefan Lönn, Anders Ahlbom, Beatrice Malmer, Roger Henriksson, Anssi Auvinen, Anne Kiuru, Tiina Salminen, Christoffer Johansen, Helle Collatz Christensen, Michael Kosteljanetz, Anthony Swerdlow, and Richard Houlston
J Natl Cancer Inst 2008 100: 270-276. [Abstract] [Full Text] [PDF]

Risk Perceptions and Psychosocial Outcomes of Women With Ductal Carcinoma In Situ: Longitudinal Results From a Cohort Study
Ann Partridge, Kristie Adloff, Emily Blood, E. Claire Dees, Carolyn Kaelin, Mehra Golshan, Jennifer Ligibel, Janet S. de Moor, Jane Weeks, Karen Emmons, and Eric Winer
J Natl Cancer Inst 2008 100: 243-251. [Abstract] [Full Text] [PDF]

Improved Survival of Patients With Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
Carole Fakhry, William H. Westra, Sigui Li, Anthony Cmelak, John A. Ridge, Harlan Pinto, Arlene Forastiere, and Maura L. Gillison
J Natl Cancer Inst 2008 100: 261-269. [Abstract] [Full Text] [PDF]

The Sea of Uncertainty Surrounding Ductal Carcinoma In Situ—The Price of Screening Mammography
H. Gilbert Welch, Steven Woloshin, and Lisa M. Schwartz
J Natl Cancer Inst 2008 100: 228-229. [Extract] [Full Text] [PDF]

Competing Causes of Death From a Randomized Trial of Extended Adjuvant Endocrine Therapy for Breast Cancer
Judith-Anne W. Chapman, Daniel Meng, Lois Shepherd, Wendy Parulekar, James N. Ingle, Hyman B. Muss, Michael Palmer, Changhong Yu, and Paul E. Goss
J Natl Cancer Inst 2008 100: 252-260. [Abstract] [Full Text] [PDF]

Time to Remove the Subspecialty Blinders: Breast Cancer Does Not Exist in Isolation
Sharon H. Giordano and Gabriel N. Hortobagyi
J Natl Cancer Inst 2008 100: 230-231. [Extract] [Full Text] [PDF]